The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet's disease

被引:47
作者
Köse, K [1 ]
Yazici, C
Asçioglu, Ö
机构
[1] Erciyes Univ, Fac Med, Dept Biochem, TR-38039 Kayseri, Turkey
[2] Erciyes Univ, Fac Med, Dept Dermatol, TR-38039 Kayseri, Turkey
关键词
Behcet's disease; adenosine deaminase; malondialdehyde;
D O I
10.1016/S0009-9120(01)00190-4
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: Despite unknown etiology, immunologic alterations and neutrophil hyperfunctions may be involved in the etiopathogenesis of Behcet's Disease (BD). The purpose of the study was to investigate whether adenosine deaminase (ADA) activity, accepted as a nonspecific marker of T lymphocyte activation, may have a potential role in ED. and also may be related to the production of reactive oxygen species (ROS) by neutrophils. Design and methods: ADA activities and malondialdehyde (MDA; endproduct of lipid peroxidation induced by ROS) levels in both plasma and erythrocytes were spectrophotometrically measured in 25 patients with BD and also in 25 healthy controls. Results: ADA activity was found to be higher in plasma, but lower in erythrocytes; plasma and erythrocyte MDA levels were higher in ED patients than those of controls. In addition, plasma ADA activity was positively related to MDA levels in both plasma (p < 0.05) and erythrocytes (p < 0.01). There was also positive correlation between MDA levels (p < 0.05), but negative correlations between ADA activities (p < 0.01) and also between ADA and MDA values in erythrocytes (p < 0.01) of ED patients. Conclusion: These findings may provide some evidence for a potential role of T lymphocyte activation in ED as reflected by increased plasma ADA activity, and for the presence of possible interrelationship between activated T cells and neutrophil hyperfunctions. such as ROS generation, as reflected by increased MDA levels. (C) 2001 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 32 条
[1]  
ADAMS A, 1976, CLIN EXP IMMUNOL, V26, P647
[2]  
Behçet H, 1937, DERMATOL WOCHENSCHR, V105, P1152
[3]  
Bükülmez G, 2000, EUR J DERMATOL, V10, P274
[4]   Sequential evaluation of serum adenosine deaminase in patients treated for tuberculosis [J].
Collazos, J ;
España, P ;
Mayo, J ;
Martínez, E ;
Izquierdo, F .
CHEST, 1998, 114 (02) :432-435
[5]   OXIDATIVE-ENZYMES OF POLYMORPHONUCLEAR LEUKOCYTES AND PLASMA-FIBRINOGEN, CERULOPLASMIN, AND COPPER LEVELS IN BEHCETS-DISEASE [J].
DOGAN, P ;
TANRIKULU, G ;
SOYUER, U ;
KOSE, K .
CLINICAL BIOCHEMISTRY, 1994, 27 (05) :413-418
[6]   Clastogenic activity in the plasma of scleroderma patients: A biomarker of oxidative stress [J].
Emerit, I ;
Filipe, P ;
Meunier, P ;
Auclair, C ;
Freitas, J ;
Deroussent, A ;
Gouyette, A ;
Fernandes, A .
DERMATOLOGY, 1997, 194 (02) :140-146
[7]   Oxidative Stress in Adamantiades-Behcet's disease [J].
Freitas, JP ;
Filipe, P ;
Yousefi, A ;
Emerit, I ;
Rodrigo, FG .
DERMATOLOGY, 1998, 197 (04) :343-348
[8]   Behcet's disease and complex aphthosis [J].
Ghate, JV ;
Jorizzo, JL .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (01) :1-18
[9]  
Giusti G, 1984, METHOD ENZYMAT AN, V4, P315
[10]   REACTIVE OXYGEN SPECIES IN LIVING SYSTEMS - SOURCE, BIOCHEMISTRY, AND ROLE IN HUMAN-DISEASE [J].
HALLIWELL, B .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S14-S22